Cargando…

Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background

Cyclooxygenase 2 (COX-2) is a key enzyme of the tumorigenesis-inflammation interface and can be induced by hypoxia. A pseudohypoxic transcriptional signature characterizes pheochromocytomas and paragangliomas (PPGLs) of the cluster I, mainly represented by tumors with mutations in von Hippel–Lindau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ullrich, Martin, Richter, Susan, Seifert, Verena, Hauser, Sandra, Calsina, Bruna, Martínez-Montes, Ángel M., ter Laak, Marjolein, Ziegler, Christian G., Timmers, Henri, Eisenhofer, Graeme, Robledo, Mercedes, Pietzsch, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627450/ https://www.ncbi.nlm.nih.gov/pubmed/31142060 http://dx.doi.org/10.3390/cancers11060743

Ejemplares similares

Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
por: Cascón, Alberto, et al.
Publicado: (2019)

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
por: Nölting, Svenja, et al.
Publicado: (2019)

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors
por: Ghayee, Hans Kumar, et al.
Publicado: (2020)

Update on Modern Management of Pheochromocytoma and Paraganglioma
por: Lenders, Jacques W. M., et al.
Publicado: (2017)

Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion
por: Li, Minghao, et al.
Publicado: (2021)

Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging
por: Rogowski-Lehmann, Natalie, et al.
Publicado: (2018)

Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells
por: Bechmann, Nicole, et al.
Publicado: (2019)

Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses
por: Fischer, Alessa, et al.
Publicado: (2023)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

THU612 SDHx Pheochromocytoma/Paraganglioma Has Elevation Of Arginine And Lysine Metabolites
por: Ghayee, Hans Kumar, et al.
Publicado: (2023)

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
por: Gieldon, Laura, et al.
Publicado: (2019)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
por: Calsina, Bruna, et al.
Publicado: (2023)

Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
por: Eisenhofer, Graeme, et al.
Publicado: (2022)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Overexpression of miR‐483‐5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma
por: Castro‐Vega, Luis Jaime, et al.
Publicado: (2020)

Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
por: Richter, Susan, et al.
Publicado: (2018)

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma
por: Rao, Dipti, et al.
Publicado: (2017)

DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling
por: Mellid, Sara, et al.
Publicado: (2023)

Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
por: Ullrich, Martin, et al.
Publicado: (2018)

Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology
por: Constantinescu, Georgiana, et al.
Publicado: (2022)

HIF2alpha-Associated Pseudohypoxia Promotes Radioresistance in Pheochromocytoma: Insights from 3D Models
por: Seifert, Verena, et al.
Publicado: (2021)

Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma
por: Maison, Nicole, et al.
Publicado: (2016)

Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma
por: Bliziotis, Nikolaos G., et al.
Publicado: (2021)

Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
por: Monteagudo, María, et al.
Publicado: (2021)

Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
por: Mellid, Sara, et al.
Publicado: (2023)

PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2022)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells
por: Brandt, Florian, et al.
Publicado: (2022)

Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
por: Brazda, Peter, et al.
Publicado: (2022)

Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension
por: Constantinescu, Georgiana, et al.
Publicado: (2020)

Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma
por: Pang, Yingxian, et al.
Publicado: (2022)

Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)

Characteristics of Pediatric Pheochromocytoma/paraganglioma
por: Sarathi, Vijaya
Publicado: (2017)

Review of Pediatric Pheochromocytoma and Paraganglioma
por: Bholah, Reshma, et al.
Publicado: (2017)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

Dopamine-Secreting Pheochromocytoma and Paraganglioma
por: Miyamoto, Shotaro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lmkam5hkr3ckllgfkqgcjk8lh4